top of page
Market Access - Brazil
HTAnalyze supports organizations in critical market access, pricing, and value demonstration projects by integrating clinical evidence, HEOR (Health Economics and Outcomes Research), budget impact analysis, and RWE (Real-World Evidence) into robust, transparent, and traceable deliverables.
We operate extensively across key healthcare decision-making pathways in Brazil, including Conitec, ANS, and CMED, and have the technical capacity to support international market access and reimbursement strategies.

bottom of page





